2018
DOI: 10.1016/j.ejphar.2018.07.029
|View full text |Cite
|
Sign up to set email alerts
|

Fentanyl and naloxone effects on glutamate and GABA release rates from anterior hypothalamus in freely moving rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 46 publications
0
5
0
Order By: Relevance
“…We hypothesized that the isoflurane MAC‐sparing effects observed with some phenylpiperidine opioids might be mediated by nonopioid receptor effects. Fentanyl decreases neuronal release of acetylcholine to reduce muscarinic cholinergic activity (Mortazavi, Thompson, Baghdoyan, & Lydic, 1999), decreases release of glutamate that may reduce excitatory NMDA receptor currents, and increases release of γ‐aminobutyric acid (GABA) that may enhance inhibitory GABA A receptor currents (Pourzitaki et al., 2018). Additionally, various opioids at sufficient concentrations can directly modulate NMDA receptors (Hahnenkamp et al., 2004), α 1 ‐adrenergic receptors (Toda & Hatano, 1977), α 2 ‐adrenergic receptors (Hocker et al., 2008, 2009), dopamine receptors (Hagelberg et al., 2002), serotonin receptors (Leysen & Gommeren, 1986), voltage‐gated sodium channels (Leffler et al., 2012), and potassium channels (Tschirhart, Li, Guo, & Zhang, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…We hypothesized that the isoflurane MAC‐sparing effects observed with some phenylpiperidine opioids might be mediated by nonopioid receptor effects. Fentanyl decreases neuronal release of acetylcholine to reduce muscarinic cholinergic activity (Mortazavi, Thompson, Baghdoyan, & Lydic, 1999), decreases release of glutamate that may reduce excitatory NMDA receptor currents, and increases release of γ‐aminobutyric acid (GABA) that may enhance inhibitory GABA A receptor currents (Pourzitaki et al., 2018). Additionally, various opioids at sufficient concentrations can directly modulate NMDA receptors (Hahnenkamp et al., 2004), α 1 ‐adrenergic receptors (Toda & Hatano, 1977), α 2 ‐adrenergic receptors (Hocker et al., 2008, 2009), dopamine receptors (Hagelberg et al., 2002), serotonin receptors (Leysen & Gommeren, 1986), voltage‐gated sodium channels (Leffler et al., 2012), and potassium channels (Tschirhart, Li, Guo, & Zhang, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Nitrous oxide was also used in cats, which inhibits N -methyl-D-aspartate channels [31]. Opioids, such as sufentanil, generate increases in GABA release, amongst other effects [32]. In general, the enhancement of GABA is similar between anaesthetics but they may differ enough in detail to influence the percentage of contrast-dependent phase-sensitive cells in V1.…”
Section: Discussionmentioning
confidence: 99%
“…A study on neurotransmitter release rate in the hypothalamus found that rats treated with fentanyl for 75 min had slower glutamate and faster GABA release. However, no comment was made on total metabolite levels [ 152 ]. Rapidly proliferating cancer cells depend on glutamine uptake for anapleorosis into the TCA cycle to eventually produce ATP, NADH, and FADH 2 .…”
Section: Glutamine Metabolismmentioning
confidence: 99%